EDGE MEDICAL-B's stock soared 6.74% during intraday trading on Monday, reflecting strong investor sentiment.
The surge follows the company's release of its 2025 financial results, which showed a significant improvement in performance. Shenzhen Edge Medical reported a narrower attributable loss of 88.6 million yuan for 2025, compared to a loss of 218.5 million yuan in the prior year. Concurrently, the company's revenue nearly tripled, surging 185% to 455.7 million yuan.
This substantial revenue growth and reduced loss demonstrate positive operational momentum, which likely fueled the buying interest and drove the stock price higher in the session.
Comments